Sanjiv Patel, President and CEO at Relay Therapeutics, Inc. (RLAY), sold 48,199 shares at $18.94 ($913K) on 2026-09-08, disclosed to the SEC on 2026-09-09.
Scheduled sale ($913k) by President and CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| RLAY | SELL | 2026-07-08 | $944K | — | Filing → |
| RLAY | SELL | 2026-01-07 | $338K | — | Filing → |
| RLAY | SELL | 2025-11-04 | $435K | — | Filing → |